| The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment J van Ingen, EF Egelund, A Levin, SE Totten, MJ Boeree, JW Mouton, ... American journal of respiratory and critical care medicine 186 (6), 559-565, 2012 | 199 | 2012 |
| CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics? A Owusu Obeng, EF Egelund, A Alsultan, CA Peloquin, JA Johnson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (7 …, 2014 | 144 | 2014 |
| Medications and monitoring in nontuberculous mycobacteria infections EF Egelund, KP Fennelly, CA Peloquin Clinics in Chest Medicine 36 (1), 55-66, 2015 | 75 | 2015 |
| Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers M Weiner, EF Egelund, M Engle, M Kiser, TJ Prihoda, JAL Gelfond, ... Journal of Antimicrobial Chemotherapy 69 (4), 1079-1085, 2014 | 70 | 2014 |
| Integrase inhibitors: after 10 years of experience, is the best yet to come? KM Brooks, EM Sherman, EF Egelund, A Brotherton, S Durham, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (5 …, 2019 | 61 | 2019 |
| Optimizing the clinical pharmacology of tuberculosis medications EF Egelund, A Alsultan, CA Peloquin Clinical Pharmacology & Therapeutics 98 (4), 387-393, 2015 | 55 | 2015 |
| Treatment of Mycobacterium avium complex (MAC) DE Griffith Seminars in respiratory and critical care medicine 39 (03), 351-361, 2018 | 51 | 2018 |
| Using interprofessional medication management simulations to impact student attitudes toward teamwork to prevent medication errors C Motycka, EF Egelund, J Gannon, F Genuardi, S Gautam, S Stittsworth, ... Currents in Pharmacy Teaching and Learning 10 (7), 982-989, 2018 | 40 | 2018 |
| Teaching End-of-Life Care Using Interprofessional Simulation. SK Gannon J, Motycka CA, Egelund EF, Kraemer DF, Smith WT Journal of Nursing Education 56 (4), 205-210, 2017 | 39 | 2017 |
| Tenofovir alafenamide for the treatment of chronic hepatitis B monoinfection LM Childs‐Kean, EF Egelund, J Jourjy Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (10 …, 2018 | 33 | 2018 |
| Voriconazole monitoring in children with invasive fungal infections L Tucker, T Higgins, EF Egelund, B Zou, V Vijayan, CA Peloquin The Journal of Pediatric Pharmacology and Therapeutics 20 (1), 17-23, 2015 | 31 | 2015 |
| A HAART‐breaking review of alternative antiretroviral administration: practical considerations with crushing and enteral tube scenarios E Huesgen, KE DeSear, EF Egelund, R Smith, B Max, J Janelle Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (11 …, 2016 | 27 | 2016 |
| Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis EF Egelund, M Weiner, RP Singh, TJ Prihoda, JAL Gelfond, H Derendorf, ... Antimicrobial agents and chemotherapy 58 (8), 4904-4910, 2014 | 23 | 2014 |
| Blood pressure lowering in patients with diabetes—one level might not fit all RM Cooper-DeHoff, EF Egelund, CJ Pepine Nature Reviews Cardiology 8 (1), 42-49, 2011 | 23 | 2011 |
| The pharmacological challenges of treating tuberculosis and HIV coinfections EF Egelund, L Dupree, E Huesgen, CA Peloquin Expert Review of Clinical Pharmacology 10 (2), 213-223, 2017 | 22 | 2017 |
| Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment E Free Egelund, A Bergesch Barth, C Arthur Peloquin Current pharmaceutical design 17 (27), 2889-2899, 2011 | 21 | 2011 |
| The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus) A P. Brock, R Isaza, EF Egelund, RP Hunter, CA Peloquin Journal of veterinary pharmacology and therapeutics 37 (5), 472-479, 2014 | 13 | 2014 |
| Editorial Commentary: Pharmacokinetic Variability and Tuberculosis Treatment Outcomes, Including Acquired Drug Resistance EF Egelund, CA Peloquin Clinical infectious diseases 55 (2), 178-179, 2012 | 12 | 2012 |
| Posaconazole pharmacokinetics in a 2‐year‐old boy with rhino‐cerebral‐orbital zygomycosis EF Egelund, TA Egelund, JS Ng, SK Wassil, CA Peloquin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (1 …, 2013 | 11 | 2013 |
| A simulated approach to fostering competency in end-of-life care among pharmacy students EF Egelund, J Gannon, C Motycka, WT Smith, DF Kraemer, KH Solomon American journal of pharmaceutical education 83 (4), 6904, 2019 | 10 | 2019 |
Charles PeloquinProfessor of Pharmacy, University of Florida在 cop.ufl.edu 的电子邮件经过验证
